Global Infertility Devices Market, by Product Type (Equipment and Accessories), by Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery, and Others), by Gender (Male and Female), by End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 7,104.1 million in 2018, and is expected to exhibit a CAGR of 8.4% over the forecast period (2019-2027).

Increasing adoption of collaborations and partnerships by key players are expected to propel the market growth over the forecast period. For instance, in October 2019, Carl Zeiss Meditec AG entered into a partnership with Kyoto University to increase the company’s research and development capabilities. Similarly, in November 2019, Invo Bioscience announced that they have entered commercialization agreements for the InvoCell in-vivo fertility system in Turkey and Jordan, to support the company’s expansion into Middle East.

Rising prevalence of infertility is expected to boost growth of the infertility devices market over the forecast period. For instance, according to the International Journal of Women’s Health and Reproduction Sciences, in 2018, the global prevalence of infertility was 10-15%. According to the same data source, in Iran, couples suffering from primary and secondary fertility problems were around 78.4% and 21.6%, respectively in 2018.

Moreover, increasing government funding programs for infertility is further expected to drive the infertility devices market growth over the forecast period. For instance, in December 2015, Ontario (Canada) government launched the Ontario Fertility Program to provide funds to help infertile patients to overcome such infertility problems. Moreover, access to funded fertility services was available for all forms of infertility (including medical and non-medical infertility), regardless of gender, sexual orientation, or family status.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2579

Browse 38 Market Data Tables and 29 Figures spread through 214 Pages and in-depth TOC on ‘Infertility Devices Market’- Global Forecast to 2027, by Product Type (Equipment and Accessories), by Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery, and Others), by Gender (Male and Female), by End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

expected to hold a dominant position in the infertility devices market over the forecast period, owing to adoption of growth strategies such as product launches, investments, and facility expansion by the market players in the region to enhance their market presence. For instance, in November 2015, INVO Bioscience, Inc., a medical device company announced that the U.S. Food and Drug Administration (FDA) approved company's De Novo request for INVOcell. INVOcell is the first intravaginal culture system that was granted marketing clearance in the U.S.

Moreover, rising adoption of inorganic growth strategies such as distribution agreement, collaborations, and acquisitions by market players in North America are expected to boost the infertility devices market growth in the region during the forecast period. For instance, in November 2018, Ferring Pharmaceuticals signed an agreement to acquire the exclusive U.S. commercialization rights for the INVOcell intravaginal culture (IVC) system from INVO Bioscience Inc. The system includes the INVOcell IVC device, retention device, and holding block.


Furthermore, Europe is expected to witness significant growth in the infertility devices market during the forecast period, owing to favorable reimbursement policies by governments for infertility treatment. For instance, according to the European Policy Audit on Fertility (EPAF) rules, there is 100% coverage for women under 43 years for four IVF treatments and up to six IUI treatments in France.

Key Takeaways of the Infertility Devices Market:

The global infertility devices market is expected to exhibit a CAGR of 8.4% over the forecast period, owing to increasing adoption of collaborations and acquisition strategies by the market players, and rising products approvals by regulatory organizations. For instance, in October 2019, INVO Bioscience, Inc., a medical device company focused on creating alternative treatments for patients diagnosed with infertility, announced about receiving the CE mark for its INVOcell culture and retention device.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/infertility-devices-market-2579

Among product type, equipment segment held dominant position in the infertility devices market in 2018, owing to increasing research and innovation in the field of fertility by the research institutes. For instance, in 2018, researcher at Worcester Polytechnic Institute developed a device named Spartan. The Spartan device helps women to get pregnant with fewer treatment trials in IVF fertilization by selecting faster and healthier sperm. The Spartan name is the short form of Simple Periodic Array for Trapping and Isolation. This device uses field of three-dimensional posts to create obstacle of array through which sperm passes to outlet. The fastest and healthiest sperm that gets into the outlet are used for further IVF (In vitro fertilization) procedure.

Among procedure, Assisted Reproductive Technology (ART) procedure segment held dominant position in the infertility devices market in 2018, owing to increasing innovation and development in ART. For instance, in 2017, Esco Medical Group launched Semi-Closed Environment (SCE) IVF device to provide controlled environment, while handling the gamete and embryo in IVF procedure.

Among gender, females segment held dominant position in the infertility devices market in 2018, owing to rising prevalence of infertility. For instance, according to the data by National Survey of Family Growth (NSFG) published in 2018 indicates that in the U.S., around 5.5% of all female population were infertile and 6.7% of married women aged 15 to 44 years were infertile.

Companies operating in the global infertility devices market include Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art Biotech Pvt. LTD

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2579

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737